More on Walgreens Boots Alliance's FQ3

• Walgreens Boots Alliance (NASDAQ:NASDAQ:WBA) reports comparable-store sales rose 1.6% in FQ3.
• Pharmacy sales grew 7% on a 3.8% gain in prescription count for the quarter.
• Gross profit margin rate decreased 206 bps to 26%.
• Adjsuted SG&A expense rate -240 bps to 20.1%.
• Adjusted operating margin rate fell 22 bps to 6.07%.
• Total drugstores count +8 Q/Q to 8,240.
• FY2015 Guidance: Adjusted EPS: $3.70 to $3.80.
• FY2016 Guidance: Adjusted EPS: $4.25 to $4.60.
• WBA +2.72% premarket.